B.‐G. Ericzon

1.1k total citations
19 papers, 856 citations indexed

About

B.‐G. Ericzon is a scholar working on Surgery, Molecular Biology and Hepatology. According to data from OpenAlex, B.‐G. Ericzon has authored 19 papers receiving a total of 856 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 6 papers in Molecular Biology and 5 papers in Hepatology. Recurrent topics in B.‐G. Ericzon's work include Organ Transplantation Techniques and Outcomes (7 papers), Liver Disease and Transplantation (5 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers). B.‐G. Ericzon is often cited by papers focused on Organ Transplantation Techniques and Outcomes (7 papers), Liver Disease and Transplantation (5 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers). B.‐G. Ericzon collaborates with scholars based in Sweden, Finland and Denmark. B.‐G. Ericzon's co-authors include Mark B. Pepys, Carl‐Gustav Groth, Markus Larsson, Ingvar Karlberg, Jan Ekstedt, Gunnela Nordén, Lars Steen, M Nakazato, Oluf Andersen and Philip N. Hawkins and has published in prestigious journals such as American Journal of Transplantation, Journal of Internal Medicine and Surgical Endoscopy.

In The Last Decade

B.‐G. Ericzon

19 papers receiving 834 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.‐G. Ericzon Sweden 10 491 216 214 162 150 19 856
Lawrence Yuen Australia 13 127 0.3× 337 1.6× 97 0.5× 70 0.4× 103 0.7× 51 732
Masaki Honda Japan 12 165 0.3× 214 1.0× 135 0.6× 127 0.8× 53 0.4× 68 739
Nozomi Koyamada Japan 15 182 0.4× 802 3.7× 103 0.5× 185 1.1× 185 1.2× 35 1.1k
Kaori Isono Japan 13 204 0.4× 223 1.0× 91 0.4× 102 0.6× 153 1.0× 51 569
A.H. Cohen United States 10 152 0.3× 164 0.8× 151 0.7× 16 0.1× 60 0.4× 20 615
Koji Yazawa Japan 11 201 0.4× 624 2.9× 62 0.3× 62 0.4× 67 0.4× 39 861
Helong Dai China 14 150 0.3× 171 0.8× 58 0.3× 47 0.3× 117 0.8× 63 601
Shaojun Ye China 16 160 0.3× 196 0.9× 91 0.4× 129 0.8× 70 0.5× 42 548
Shinichiro Yokota United States 13 164 0.3× 196 0.9× 148 0.7× 151 0.9× 68 0.5× 33 582
Alice A. Bickerstaff United States 13 104 0.2× 175 0.8× 89 0.4× 20 0.1× 195 1.3× 23 643

Countries citing papers authored by B.‐G. Ericzon

Since Specialization
Citations

This map shows the geographic impact of B.‐G. Ericzon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.‐G. Ericzon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.‐G. Ericzon more than expected).

Fields of papers citing papers by B.‐G. Ericzon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.‐G. Ericzon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.‐G. Ericzon. The network helps show where B.‐G. Ericzon may publish in the future.

Co-authorship network of co-authors of B.‐G. Ericzon

This figure shows the co-authorship network connecting the top 25 collaborators of B.‐G. Ericzon. A scholar is included among the top collaborators of B.‐G. Ericzon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.‐G. Ericzon. B.‐G. Ericzon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Watanabe, Masaaki, Makiko Kumagai‐Braesch, Sarah Thunberg, et al.. (2018). Ex Vivo Generation of Donor Antigen-Specific Immunomodulatory Cells. Cell Transplantation. 27(11). 1692–1704. 8 indexed citations
2.
3.
Ankarcrona, Maria, Bengt Winblad, Cecília Monteiro, et al.. (2016). Current and future treatment of amyloid diseases. Journal of Internal Medicine. 280(2). 177–202. 73 indexed citations
4.
Yamamoto, Shinji, H Wilczek, Frans Duraj, C. G. Groth, & B.‐G. Ericzon. (2010). Liver Transplantation with Grafts from Controlled Donors after Cardiac Death: A 20‐Year Follow‐up at a Single Center. American Journal of Transplantation. 10(3). 602–611. 33 indexed citations
5.
Trunečka, Pavel, Olivier Boillot, Daniel Seehofer, et al.. (2010). Once‐Daily Prolonged‐Release Tacrolimus (ADVAGRAF) Versus Twice‐Daily Tacrolimus (PROGRAF) in Liver Transplantation. American Journal of Transplantation. 10(10). 2313–2323. 93 indexed citations
6.
7.
Iwata, Tsuyoshi, et al.. (2007). Microdialysis monitoring for evaluation of the influence exerted by pneumoperitoneum on the kidney: an experimental study. Surgical Endoscopy. 22(4). 938–942. 2 indexed citations
8.
Yamamoto, Shigehiro, H Wilczek, Gabriel Nowak, et al.. (2007). Liver Transplantation for Familial Amyloidotic Polyneuropathy (FAP): A Single‐Center Experience Over 16 Years. American Journal of Transplantation. 7(11). 2597–2604. 146 indexed citations
9.
Bäckman, L, Anna Varberg Reisæter, Lars Wramner, et al.. (2006). Renal function in renal or liver transplant recipients after conversion from a calcineurin inhibitor to sirolimus. Clinical Transplantation. 20(3). 336–339. 8 indexed citations
10.
Friman, S., Ulrika Broomé, Helena Isoniemi, et al.. (2003). Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries. Scandinavian Journal of Gastroenterology. 38(11). 1176–1183. 46 indexed citations
11.
Herlenius, Gustaf, Markus Larsson, & B.‐G. Ericzon. (2001). Results from the familial amyloidotic polyneuropathy world transplant registry. Transplantation Proceedings. 33(4). 2454–2454. 9 indexed citations
12.
Herlenius, Gustaf, Markus Larsson, & B.‐G. Ericzon. (2001). FAP World Transplant Register and domino/sequential register update. Transplantation Proceedings. 33(1-2). 1367–1367. 5 indexed citations
13.
Herlenius, Gustaf, Markus Larsson, & B.‐G. Ericzon. (2001). Familial Amyloidotic Polyneuropathy World Transplant Registry. 19 indexed citations
14.
Barkholt, Lisbeth, et al.. (1999). High‐dose acyclovir prophylaxis reduces cytomegalovirus disease in liver transplant patients. Transplant Infectious Disease. 1(2). 89–97. 39 indexed citations
15.
Tollemar, J, Krister Höckerstedt, B.‐G. Ericzon, Hannu Jalanko, & Olle Ringdén. (1995). Prophylaxis with liposomal amphotericin B (AmBisome) prevents fungal infections in liver transplant recipients: long-term results of a randomized, placebo-controlled trial.. PubMed. 27(1). 1195–8. 35 indexed citations
16.
Wijnen, René, B.‐G. Ericzon, A.T.M.G. Tiebosch, et al.. (1992). Toxicology of FK506 in the cynomolgus monkey: a clinical, biochemical, and histopathological study. Transplant International. 5. S454–S458. 13 indexed citations
17.
Tollemar, J & B.‐G. Ericzon. (1991). Invasive Candida albicans infections in orthotopic liver graft recipients. Incidence and risk‐factors. Clinical Transplantation. 5(4). 306–312. 4 indexed citations
18.
Holmgren, Gösta, Lars Steen, Jan Ekstedt, et al.. (1991). Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP‐met30). Clinical Genetics. 40(3). 242–246. 302 indexed citations
19.
Ericzon, B.‐G., et al.. (1990). Biliary lipid secretion early after liver transplantation.. PubMed. 22(4). 1537–8. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026